Post-trial obligations - DOI: 10.3395/reciis.v2.Sup1.210en

In its essence, post-trial obligations describe a duty by research sponsors to provide a successfully tested drug to research participants who took part in the relevant clinical trials after the trial has been concluded. In some instances, this duty is extended beyond the research participants. This...

Full description

Bibliographic Details
Main Author: Doris Schroeder
Format: Article
Language:English
Published: Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict) da Fundação Oswaldo Cruz (Fiocruz) 2008-12-01
Series:RECIIS
Subjects:
Online Access:http://www.reciis.cict.fiocruz.br/index.php/reciis/article/view/210/188